WEKO3
アイテム
{"_buckets": {"deposit": "825be522-99b7-4e80-a286-140c795d45c5"}, "_deposit": {"id": "3914", "owners": [], "pid": {"revision_id": 0, "type": "depid", "value": "3914"}, "status": "published"}, "_oai": {"id": "oai:nagoya.repo.nii.ac.jp:00003914", "sets": ["510"]}, "item_9_biblio_info_6": {"attribute_name": "書誌情報", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "1999-11", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "3-4", "bibliographicPageEnd": "82", "bibliographicPageStart": "77", "bibliographicVolumeNumber": "62", "bibliographic_titles": [{"bibliographic_title": "Nagoya Journal of Medical Science"}]}]}, "item_9_description_4": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "Over the last ten years, recombinant human granulocyte colony-stimulating factor (rh G-CSF) has been widely used in the treatment of aplastic anemia (AA). It has been shown to facilitate the recovery of neutrophil count and useful for complicated bacterial or fungal infections. However, recent randomized clinical trials showed that the addition of rh G-CSF to immunosuppressive therapy had no clinical benefit for the prophylaxis of severe infections. These results suggested that rh G-CSF should be used for the treatment of infectious complications, not for the prophylaxis of infections in patients with AA.", "subitem_description_type": "Abstract"}]}, "item_9_identifier_60": {"attribute_name": "URI", "attribute_value_mlt": [{"subitem_identifier_type": "HDL", "subitem_identifier_uri": "http://hdl.handle.net/2237/5344"}]}, "item_9_identifier_registration": {"attribute_name": "ID登録", "attribute_value_mlt": [{"subitem_identifier_reg_text": "10.18999/nagjms.62.3-4.77", "subitem_identifier_reg_type": "JaLC"}]}, "item_9_publisher_32": {"attribute_name": "出版者", "attribute_value_mlt": [{"subitem_publisher": "Nagoya University School of Medicine"}]}, "item_9_select_15": {"attribute_name": "著者版フラグ", "attribute_value_mlt": [{"subitem_select_item": "publisher"}]}, "item_9_text_14": {"attribute_name": "フォーマット", "attribute_value_mlt": [{"subitem_text_value": "application/pdf"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "Kojima, Seiji"}], "nameIdentifiers": [{"nameIdentifier": "9953", "nameIdentifierScheme": "WEKO"}]}]}, "item_files": {"attribute_name": "ファイル情報", "attribute_type": "file", "attribute_value_mlt": [{"accessrole": "open_date", "date": [{"dateType": "Available", "dateValue": "2018-02-19"}], "displaytype": "detail", "download_preview_message": "", "file_order": 0, "filename": "nj6231.pdf", "filesize": [{"value": "41.5 kB"}], "format": "application/pdf", "future_date_message": "", "is_thumbnail": false, "licensetype": "license_free", "mimetype": "application/pdf", "size": 41500.0, "url": {"label": "nj6231.pdf", "url": "https://nagoya.repo.nii.ac.jp/record/3914/files/nj6231.pdf"}, "version_id": "89989605-b4e1-442b-85d8-e451cd5a5acf"}]}, "item_keyword": {"attribute_name": "キーワード", "attribute_value_mlt": [{"subitem_subject": "aplastic anemia", "subitem_subject_scheme": "Other"}, {"subitem_subject": "granulocyte colony-stimulating factor", "subitem_subject_scheme": "Other"}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "departmental bulletin paper", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "Use of granulocyte colony-stimulating factor for treatment of aplastic anemia", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "Use of granulocyte colony-stimulating factor for treatment of aplastic anemia"}]}, "item_type_id": "9", "owner": "1", "path": ["510"], "permalink_uri": "https://doi.org/10.18999/nagjms.62.3-4.77", "pubdate": {"attribute_name": "公開日", "attribute_value": "2006-02-03"}, "publish_date": "2006-02-03", "publish_status": "0", "recid": "3914", "relation": {}, "relation_version_is_last": true, "title": ["Use of granulocyte colony-stimulating factor for treatment of aplastic anemia"], "weko_shared_id": null}
Use of granulocyte colony-stimulating factor for treatment of aplastic anemia
https://doi.org/10.18999/nagjms.62.3-4.77
https://doi.org/10.18999/nagjms.62.3-4.775640bc39-fdf9-4586-a50d-23bf512df53a
名前 / ファイル | ライセンス | アクション |
---|---|---|
![]() |
|
Item type | 紀要論文 / Departmental Bulletin Paper(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2006-02-03 | |||||
タイトル | ||||||
タイトル | Use of granulocyte colony-stimulating factor for treatment of aplastic anemia | |||||
著者 |
Kojima, Seiji
× Kojima, Seiji |
|||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | aplastic anemia | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | granulocyte colony-stimulating factor | |||||
抄録 | ||||||
内容記述 | Over the last ten years, recombinant human granulocyte colony-stimulating factor (rh G-CSF) has been widely used in the treatment of aplastic anemia (AA). It has been shown to facilitate the recovery of neutrophil count and useful for complicated bacterial or fungal infections. However, recent randomized clinical trials showed that the addition of rh G-CSF to immunosuppressive therapy had no clinical benefit for the prophylaxis of severe infections. These results suggested that rh G-CSF should be used for the treatment of infectious complications, not for the prophylaxis of infections in patients with AA. | |||||
内容記述タイプ | Abstract | |||||
出版者 | ||||||
出版者 | Nagoya University School of Medicine | |||||
言語 | ||||||
言語 | eng | |||||
資源タイプ | ||||||
資源 | http://purl.org/coar/resource_type/c_6501 | |||||
タイプ | departmental bulletin paper | |||||
ID登録 | ||||||
ID登録 | 10.18999/nagjms.62.3-4.77 | |||||
ID登録タイプ | JaLC | |||||
書誌情報 |
Nagoya Journal of Medical Science 巻 62, 号 3-4, p. 77-82, 発行日 1999-11 |
|||||
フォーマット | ||||||
application/pdf | ||||||
著者版フラグ | ||||||
値 | publisher | |||||
URI | ||||||
識別子 | http://hdl.handle.net/2237/5344 | |||||
識別子タイプ | HDL |